Journal of Lipid Research, Vol 30, 247-261, Copyright © 1989 by Lipid Research, Inc.

ARTICLES

Inhibitors of sterol synthesis. Chemical synthesis, structure, and biological activities of (25R)-3 beta,26-dihydroxy-5 alpha-cholest- 8(14)-en-15-one, a metabolite of 3 beta-hydroxy-5 alpha-cholest-8(14)- en-15-one

HS Kim, WK Wilson, DH Needleman, FD Pinkerton, DK Wilson, FA Quiocho and GJ Schroepfer Jr
Department of Biochemistry, Rice University, Houston, TX 77251.

3 beta-Hydroxy-5 alpha-cholest-8(14)-en-15-one (I) is a potent inhibitor of sterol synthesis with significant hypocholesterolemic activity. (25R)-3 beta,26-Dihydroxy-5 alpha-cholest-8(14)-en-15-one (II) has been shown to be a major metabolite of I after incubation with rat liver mitochondria. Described herein is the chemical synthesis of II from diosgenin. As part of this synthesis, improved conditions are described for the conversion of diosgenin to (25R)-26- hydroxycholesterol. Benzoylation of the latter compound gave (25R)- cholest-5-ene-3 beta,26-diol 3 beta,26-dibenzoate which, upon allylic bromination followed by dehydrobromination, gave (25R)-cholesta-5,7- diene-3 beta,26-diol 3 beta,26-dibenzoate. Hydrogenation-isomerization of the delta 5.7-3 beta,26-dibenzoate to (25R)-5 alpha-cholest-8(14)- ene-3 beta,26-diol 3 beta,26-bis(cyclohexanecarboxylate) followed by controlled oxidation with CrO3-dimethylpyrazole gave (25R)-3 beta,26- dihydroxy-5 alpha-cholest-8(14)-en-15-one 3 beta,26- bis(cyclohexanecarboxylate). Acid hydrolysis of the delta 8(14)-15- ketosteryl diester gave II. 13C NMR assignments are given for all synthetic intermediates and several major reaction byproducts. The structure of II was unequivocally established by X-ray crystal analysis. II was found to be highly active in the suppression of the levels of 3-hydroxy-3-methylglutaryl coenzyme A reductase in cultured mammalian cells and to inhibit oleoyl coenzyme A-dependent esterification of cholesterol in jejunal microsomes.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. Honda, G. Salen, Y. Matsuzaki, A. K. Batta, G. Xu, T. Hirayama, G. S. Tint, M. Doy, and S. Shefer Disrupted coordinate regulation of farnesoid X receptor target genes in a patient with cerebrotendinous xanthomatosis J. Lipid Res., February 1, 2005; 46(2): 287 - 296. [Abstract] [Full Text] [PDF]

				T. A. Spencer, P. Wang, D. Li, J. S. Russel, D. H. Blank, J. Huuskonen, P. E. Fielding, and C. J. Fielding Benzophenone-containing cholesterol surrogates: synthesis and biological evaluation J. Lipid Res., August 1, 2004; 45(8): 1510 - 1518. [Abstract] [Full Text] [PDF]

				Z. Zhang, D. Li, D. E. Blanchard, S. R. Lear, S. K. Erickson, and T. A. Spencer Key regulatory oxysterols in liver: analysis as {{Delta}}4-3-ketone derivatives by HPLC and response to physiological perturbations J. Lipid Res., April 1, 2001; 42(4): 649 - 658. [Abstract] [Full Text]

				A. Honda, G. Salen, Y. Matsuzaki, A. K. Batta, G. Xu, E. Leitersdorf, G. S. Tint, S. K. Erickson, N. Tanaka, and S. Shefer Differences in hepatic levels of intermediates in bile acid biosynthesis between Cyp27-/- mice and CTX J. Lipid Res., February 1, 2001; 42(2): 291 - 300. [Abstract] [Full Text]

				G. J. Schroepfer Jr. Oxysterols: Modulators of Cholesterol Metabolism and Other Processes Physiol Rev, January 1, 2000; 80(1): 361 - 554. [Abstract] [Full Text] [PDF]

				A. Honda, G. Salen, S. Shefer, A. K. Batta, M. Honda, G. Xu, G. S. Tint, Y. Matsuzaki, J. Shoda, and N. Tanaka Bile acid synthesis in the Smith-Lemli-Opitz syndrome: effects of dehydrocholesterols on cholesterol 7{alpha}-hydroxylase and 27-hydroxylase activities in rat liver J. Lipid Res., August 1, 1999; 40(8): 1520 - 1528. [Abstract] [Full Text]

				M. Axelson and O. Larsson 27-Hydroxylated Low Density Lipoprotein (LDL) Cholesterol Can Be Converted to 7alpha ,27-Dihydroxy-4-cholesten-3-one (Cytosterone) before Suppressing Cholesterol Production in Normal Human Fibroblasts. EVIDENCE THAT AN ALTERED METABOLISM OF LDL CHOLESTEROL CAN UNDERLIE A DEFECTIVE FEEDBACK CONTROL IN MALIGNANT CELLS J. Biol. Chem., May 31, 1996; 271(22): 12724 - 12736. [Abstract] [Full Text] [PDF]

				A. Honda, G. Salen, Y. Matsuzaki, A. K. Batta, G. Xu, E. Leitersdorf, G. S. Tint, S. K. Erickson, N. Tanaka, and S. Shefer Side Chain Hydroxylations in Bile Acid Biosynthesis Catalyzed by CYP3A Are Markedly Up-regulated in Cyp27-/- Mice but Not in Cerebrotendinous Xanthomatosis J. Biol. Chem., September 7, 2001; 276(37): 34579 - 34585. [Abstract] [Full Text] [PDF]